Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Genzyme Cuts Back for Future Gains: Biotechs Must Revert to Lean Growth
Seeking Alpha
Wednesday, September 15, 2010 - 7:37am
tags:
layoffs, biotech, Genzyme, Amgen, Biogen Idec, Celgene, Gilead Sciences, Sanofi
Savient Pharmaceuticals' Krystexxa Approved for Gout
Bloomberg
Wednesday, September 15, 2010 - 7:35am
tags:
Savient, gout, Krystexxa, FDA
Neurocrine: depression drug ineffective in study
Yahoo/AP
Wednesday, September 15, 2010 - 7:34am
tags:
Neurocrine, depression, GSK
GlaxoSmithKline gets $21.3M defense contract
Yahoo/AP
Wednesday, September 15, 2010 - 7:27am
tags:
defense contracts, GSK
Speculative Bubble Growing Around Diet Drugs
BNET Pharma
Tuesday, September 14, 2010 - 5:42pm
tags:
Arena Pharmaceuticals, obesity, Takeda, Orexigen, Contrave, Abbott Laboratories, Meridia, Qnexa, Vivus
2 Year-End FDA Run-Up Stock Plays
Seeking Alpha
Tuesday, September 14, 2010 - 5:41pm
tags:
FDA, pSivida, Alimera, Iluvien
Bayer resolves 200 Trasylol lawsuits
Fierce Pharma
Tuesday, September 14, 2010 - 11:40am
tags:
Bayer, lawsuits, settlements, Trasylol
K-V Pharmaceutical Enters Loan Agreement In Wake Of FDA Approval
NASDAQ.com
Tuesday, September 14, 2010 - 10:32am
tags:
KV Pharmaceutical, FDA
Cell Therapeutics to appeal FDA pixantrone decision
Bizjournals.com
Tuesday, September 14, 2010 - 10:21am
tags:
pixantrone, Cell Therapeutics, non-Hodgkin's lymphoma
Do rich markets lure biotechs away from low-cost remedies?
Fierce Biotech Research
Tuesday, September 14, 2010 - 10:19am
tags:
biotech, India, Brazil, China, South Africa
Arena's Lorcaserin: Therapeutic Value Zero?
Seeking Alpha
Tuesday, September 14, 2010 - 10:15am
tags:
Arena Pharmaceuticals, lorcaserin, obesity
BCA’s Brenner: Avastin And FDA Approval Standards
Pharmalot
Tuesday, September 14, 2010 - 10:14am
tags:
Avastin, FDA, breast cancer, Roche, Genentech
Is Celldex Therapeutics on the Rebound?
Seeking Alpha
Tuesday, September 14, 2010 - 10:02am
tags:
Celldex
Amgen Plans to Sell $1.5 Billion of Bonds in Second Debt Offering of 2010
Bloomberg
Tuesday, September 14, 2010 - 8:07am
tags:
Amgen, bonds
Ironwood, Forest boast positive IBS drug trial
Yahoo/AP
Tuesday, September 14, 2010 - 8:06am
tags:
IBS, irritable bowel syndrome, Ironwood, Forest Labs, linaclotide
Acura Pharmaceuticals Sued by Shareholder After FDA Rejects Painkiller
Bloomberg
Tuesday, September 14, 2010 - 8:03am
tags:
FDA, Acura Pharmaceuticals, shareholders, Acurox, painkillers
Bone Drug May Cause Fractures
WSJ Online
Tuesday, September 14, 2010 - 8:02am
tags:
osteoporosis, fractures, biophosphonates, Actonel, Sanofi, Boniva, Roche, GSK, Merck, Fosamax, Warner Chilcott
Forest Laboratories responds to FDA Daxas request
Yahoo/AP
Monday, September 13, 2010 - 8:25pm
tags:
FDA, Daxas
What Arena Investors Should Worry About
Forbes
Monday, September 13, 2010 - 8:22pm
tags:
Arena Pharmaceuticals, obesity, FDA
What's the Margin Trend at Endo Pharmaceuticals Holdings?
Motley Fool
Monday, September 13, 2010 - 8:21pm
tags:
Endo, Merck, JNJ, Eli Lilly, Abbott Laboratories

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.